Lee Ainslie Seagen Inc. Transaction History

Maverick Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $708,145 - $948,001	-4,967 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $755,554 - $900,725	-5,304 Reduced 51.64%	4,967 $843,000
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $159,529 - $190,259	1,181 Added 12.99%	10,271 $1.62 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $698,138 - $968,691	5,077 Added 126.51%	9,090 $1.26 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $660,660 - $850,475	4,013 New	4,013 $703,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.